{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:07:18Z","timestamp":1792789638116,"version":"4.5.0"},"reference-count":90,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:00:00Z","timestamp":1790726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Italian Association for Cancer Research","award":["30710"],"award-info":[{"award-number":["30710"]}],"id":[{"id":"https:\/\/ror.org\/02g2x7380","id-type":"ROR","asserted-by":"crossref"}]},{"award":["30710"],"award-info":[{"award-number":["30710"]}],"id":[{"id":"https:\/\/ror.org\/02g2x7380","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>Pancreatic ductal adenocarcinoma (PDAC) is the predominant histological form of pancreatic cancer and remains one of the most aggressive and therapeutically challenging malignancies [...]<\/jats:p>","DOI":"10.3390\/ijms27198735","type":"journal-article","created":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:25:42Z","timestamp":1790760342000},"page":"8735","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Special Issue \u201cMolecular Mechanisms and Therapies of Pancreatic Cancer: 2nd Edition\u201d"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4713-5298","authenticated-orcid":false,"given":"Claudia","family":"Vilardo","sequence":"first","affiliation":[{"name":"Institute of Genetics and Biophysics \u2018Adriano Buzzati-Traverso\u2019 (IGB), CNR, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Di Domenico","sequence":"additional","affiliation":[{"name":"Institute of Genetics and Biophysics \u2018Adriano Buzzati-Traverso\u2019 (IGB), CNR, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4019-2778","authenticated-orcid":false,"given":"Donatella","family":"Delle Cave","sequence":"additional","affiliation":[{"name":"Institute of Genetics and Biophysics \u2018Adriano Buzzati-Traverso\u2019 (IGB), CNR, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.annonc.2023.08.009","article-title":"Pancreatic Cancer: ESMO Clinical Practice Guideline for Diagnosis, Treatment and Follow-Up","volume":"34","author":"Conroy","year":"2023","journal-title":"Ann. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"173","DOI":"10.4251\/wjgo.v12.i2.173","article-title":"Pancreatic Ductal Adenocarcinoma: Treatment Hurdles, Tumor Microenvironment and Immunotherapy","volume":"12","author":"Sarantis","year":"2020","journal-title":"World J. Gastrointest. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","article-title":"Pancreatic Cancer: Advances and Challenges","volume":"186","author":"Halbrook","year":"2023","journal-title":"Cell"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Principe, D.R., Underwood, P.W., Korc, M., Trevino, J.G., Munshi, H.G., and Rana, A. (2021). The Current Treatment Paradigm for Pancreatic Ductal Adenocarcinoma and Barriers to Therapeutic Efficacy. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.688377"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/s41571-023-00746-1","article-title":"Neoadjuvant Therapy for Pancreatic Cancer","volume":"20","author":"Springfeld","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1053\/j.gastro.2024.05.028","article-title":"Prognostic Factors for Early Recurrence After Resection of Pancreatic Cancer: A Systematic Review and Meta-Analysis","volume":"167","author":"Leonhardt","year":"2024","journal-title":"Gastroenterology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1245\/s10434-013-3289-7","article-title":"Intensity of Follow-up after Pancreatic Cancer Resection","volume":"21","author":"Castellanos","year":"2014","journal-title":"Ann. Surg. Oncol."},{"key":"ref_8","first-page":"e70035","article-title":"Advances in Pancreatic Cancer Early Diagnosis, Prevention, and Treatment: The Past, the Present, and the Future","volume":"76","author":"Mannucci","year":"2026","journal-title":"CA A Cancer J. Clin."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41571-025-01019-9","article-title":"Improving Outcomes of Patients with Pancreatic Cancer","volume":"22","author":"Dreyer","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/SLA.0000000000006142","article-title":"Progression of Site-Specific Recurrence of Pancreatic Cancer and Implications for Treatment","volume":"280","author":"Rompen","year":"2024","journal-title":"Ann. Surg."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Cao, W., Li, J., Wang, M., Zhang, W., Wang, B., Shi, D., Li, M., and Wei, W. (2025). Postoperative Early Recurrence Prediction of Pancreatic Cancer Based on CT and Pathomics. BMC Gastroenterol., 25.","DOI":"10.1186\/s12876-025-04507-5"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Poruk, K.E., Davila, A.V., Tice, M., and Stauffer, J.A. (2026). Impact of Post-Operative Complications on Patient Outcomes and Adjuvant Chemotherapy after Surgery for Pancreatic Adenocarcinoma. J. Gastrointest. Surg. Open, 100033.","DOI":"10.1016\/j.jogsop.2026.100033"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/S1470-2045(24)00511-4","article-title":"Comparison of First-Line Chemotherapy Regimens in Unresectable Locally Advanced or Metastatic Pancreatic Cancer: A Systematic Review and Bayesian Network Meta-Analysis","volume":"25","author":"Mastrantoni","year":"2024","journal-title":"Lancet Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.sopen.2024.07.010","article-title":"Predictors of Occult Metastases in Potentially Resectable Pancreatic Ductal Adenocarcinoma","volume":"20","author":"Murakami","year":"2024","journal-title":"Surg. Open Sci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.annonc.2020.11.013","article-title":"Reshaping Preoperative Treatment of Pancreatic Cancer in the Era of Precision Medicine","volume":"32","author":"Casolino","year":"2021","journal-title":"Ann. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"116160","DOI":"10.1016\/j.ejca.2025.116160","article-title":"Metastatic Pancreatic Adenocarcinoma: Real-World Efficacy of First Line Treatment","volume":"232","author":"Debiais","year":"2026","journal-title":"Eur. J. Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1056\/NEJMoa2605555","article-title":"Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer","volume":"395","author":"Wainberg","year":"2026","journal-title":"N. Engl. J. Med."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Aoki, T., Mori, S., and Kubota, K. (2024). Neoadjuvant and Adjuvant Chemotherapy for Pancreatic Adenocarcinoma: Literature Review and Our Experience of NAC-GS. Cancers, 16.","DOI":"10.3390\/cancers16050910"},{"key":"ref_19","first-page":"10","article-title":"Cancer Statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA A Cancer J. Clin."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-Gil, J.C., Campa, D., Rizzato, C., Espinet, E., Barreto, E., Sainz, B., and Earl, J. (2026). Unifying Functional Experimental Systems with Clinical Predictive Technologies for Personalized Care in PDAC. Mol. Cancer.","DOI":"10.1186\/s12943-026-02773-9"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.dld.2026.03.002","article-title":"Liquid Biopsy in Pancreatic Cancer: Current Advances, Limitations, and Future Perspectives","volume":"58","author":"Carrara","year":"2026","journal-title":"Dig. Liver Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/s41419-025-07859-8","article-title":"TGF-\u03921-Mediated Downregulation of L1CAM in Pancreatic Ductal Adenocarcinoma Drives Upregulation of Collagen 17A1 and MMP2, Facilitating Tumor Invasiveness and Metastasis","volume":"16","author":"Cave","year":"2025","journal-title":"Cell Death Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/s41571-025-01077-z","article-title":"The Tumour Microenvironment in Pancreatic Cancer\u2014New Clinical Challenges, but More Opportunities","volume":"22","author":"Kung","year":"2025","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Delle Cave, D. (2025). Advances in Molecular Mechanisms and Therapeutic Strategies in Colorectal Cancer: A New Era of Precision Medicine. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26010346"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e70788","DOI":"10.1002\/cam4.70788","article-title":"Fibrotic Fortresses and Therapeutic Frontiers: Pancreatic Stellate Cells and the Extracellular Matrix in Pancreatic Cancer","volume":"14","author":"Sigirli","year":"2025","journal-title":"Cancer Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2147\/HP.S52636","article-title":"The Impact of Hypoxia in Pancreatic Cancer Invasion and Metastasis","volume":"91","author":"Diaz","year":"2014","journal-title":"Hypoxia"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.semcancer.2025.06.007","article-title":"Navigating the Paradox of Senescence and Chemoresistance in Pancreatic Cancer","volume":"114","author":"Jeiroshi","year":"2025","journal-title":"Semin. Cancer Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"4271","DOI":"10.1038\/s41388-020-1289-1","article-title":"TGF-\u03921 Secreted by Pancreatic Stellate Cells Promotes Stemness and Tumourigenicity in Pancreatic Cancer Cells through L1CAM Downregulation","volume":"39","author":"Cave","year":"2020","journal-title":"Oncogene"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"799","DOI":"10.4093\/dmj.2021.0077","article-title":"Obesity, Diabetes, and Increased Cancer Progression","volume":"45","author":"Kim","year":"2021","journal-title":"Diabetes Metab. J."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Hill, J.L.E., Hill, T.G., Parslow, D., and Hill, D.J. (2025). Pancreatic Cancer and Diabetes: Insights, Hypotheses, and Next Steps. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms262110245"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/14737159.2025.2464563","article-title":"Decoding Pancreatic Cancer: Key Risk Factors across Genetics and Lifestyle","volume":"25","author":"Sharma","year":"2025","journal-title":"Expert Rev. Mol. Diagn."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e70105","DOI":"10.1002\/jgh3.70105","article-title":"Causal Exposures in Pancreatic Cancer Incidence: Insights From Mendelian Randomization Studies","volume":"9","author":"Mohamadkhani","year":"2025","journal-title":"JGH Open"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1200\/JCO.2024.42.3_suppl.660","article-title":"Does Metformin Use Effect Overall Survival for Patients with Pancreatic Cancer?","volume":"42","author":"Ramjeesingh","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"5899","DOI":"10.1038\/s41598-018-24337-8","article-title":"Metformin Decreases the Incidence of Pancreatic Ductal Adenocarcinoma Promoted by Diet-Induced Obesity in the Conditional KrasG12D Mouse Model","volume":"8","author":"Chang","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Incio, J., Suboj, P., Chin, S.M., Vardam-Kaur, T., Liu, H., Hato, T., Babykutty, S., Chen, I., Deshpande, V., and Jain, R.K. (2015). Metformin Reduces Desmoplasia in Pancreatic Cancer by Reprogramming Stellate Cells and Tumor-Associated Macrophages. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0141392"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Lonardo, E., Cioffi, M., Sancho, P., Sanchez-Ripoll, Y., Trabulo, S.M., Dorado, J., Balic, A., Hidalgo, M., and Heeschen, C. (2013). Metformin Targets the Metabolic Achilles Heel of Human Pancreatic Cancer Stem Cells. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0076518"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1093\/jnci\/djae070","article-title":"for the Dutch Pancreatic Cancer Group (DPCG) Metformin Boosts Antitumor Immunity and Improves Prognosis in Upfront Resected Pancreatic Cancer: An Observational Study","volume":"116","author":"Vadgama","year":"2024","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.21037\/jgo-2025-457","article-title":"Metformin Reshapes the Tumor Microenvironment and Enhances Prognosis in Invasive Pancreatic Ductal Adenocarcinoma with Diabetes Mellitus","volume":"16","author":"Takahashi","year":"2025","journal-title":"J. Gastrointest. Oncol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Cristov\u00e3o, A., Andrade, N., Martel, F., and Silva, C. (2024). Effect of Sodium-Glucose Co-Transporter 2 Inhibitors Combined with Metformin on Pancreatic Cancer Cell Lines. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25189932"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s13046-024-03072-1","article-title":"Three-Dimensional Environment Sensitizes Pancreatic Cancer Cells to the Anti-Proliferative Effect of Budesonide by Reprogramming Energy Metabolism","volume":"43","author":"Ibello","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1186\/s12967-025-07164-0","article-title":"Metabolic and Immune Crosstalk between Cancer-Associated Fibroblasts and Pancreatic Cancer Cells","volume":"23","author":"Zhang","year":"2025","journal-title":"J. Transl. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12943-026-02628-3","article-title":"Spatially-Resolved Subtype Progression Reveals Metabolic Vulnerabilities in Pancreatic Ductal Adenocarcinoma","volume":"25","author":"Schmitt","year":"2026","journal-title":"Mol. Cancer"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41392-025-02546-8","article-title":"Glycolytic Heterogeneity Drives Metabolic-Targeted Therapy in Pancreatic Ductal Adenocarcinoma","volume":"11","author":"Chianese","year":"2026","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"5265","DOI":"10.1038\/s41467-020-18954-z","article-title":"Exploiting Oxidative Phosphorylation to Promote the Stem and Immunoevasive Properties of Pancreatic Cancer Stem Cells","volume":"11","author":"Valle","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"104483","DOI":"10.1016\/j.isci.2022.104483","article-title":"Exploring the Metabolic Landscape of Pancreatic Ductal Adenocarcinoma Cells Using Genome-Scale Metabolic Modeling","volume":"25","author":"Islam","year":"2022","journal-title":"iScience"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1158\/0008-5472.CAN-24-3475","article-title":"PPAR\u03b4 Orchestrates a Prometastatic Metabolic Response to Microenvironmental Cues in Pancreatic Cancer","volume":"85","author":"Barneda","year":"2025","journal-title":"Cancer Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ccell.2016.12.006","article-title":"Employing Metabolism to Improve the Diagnosis and Treatment of Pancreatic Cancer","volume":"31","author":"Halbrook","year":"2017","journal-title":"Cancer Cell"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/s41575-021-00431-7","article-title":"Harnessing Metabolic Dependencies in Pancreatic Cancers","volume":"18","author":"Kimmelman","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s40164-026-00795-z","article-title":"Rewiring Tumor Metabolism: Heterogeneity, Oncometabolites, and Adaptive Plasticity","volume":"15","author":"Yang","year":"2026","journal-title":"Exp. Hematol. Oncol."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"De La Cruz-L\u00f3pez, K.G., Castro-Mu\u00f1oz, L.J., Reyes-Hern\u00e1ndez, D.O., Garc\u00eda-Carranc\u00e1, A., and Manzo-Merino, J. (2019). Lactate in the Regulation of Tumor Microenvironment and Therapeutic Approaches. Front. Oncol., 9.","DOI":"10.3389\/fonc.2019.01143"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e15403","DOI":"10.1002\/advs.202515403","article-title":"Targeting Lactate and Lactylation in Cancer Metabolism and Immunotherapy","volume":"13","author":"Gong","year":"2026","journal-title":"Adv. Sci."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Baiskhanova, D., Menzel, M., Geismann, C., R\u00f6cken, C., Beitz, E., Sebens, S., Trauzold, A., and Sch\u00e4fer, H. (2025). Transmembrane Protease Serine 11B Modulates Lactate Transport Through SLC16A1 in Pancreatic Ductal Adenocarcinoma\u2014A Functional Link to Phenotype Heterogeneity. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26115398"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1186\/s13046-022-02516-w","article-title":"LAMC2 Marks a Tumor-Initiating Cell Population with an Aggressive Signature in Pancreatic Cancer","volume":"41","author":"Cave","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s13098-025-01750-4","article-title":"Targeting Early Diagnosis and Treatment of Pancreatic Cancer among the Diabetic Population: A Comprehensive Review of Biomarker Screening Strategies","volume":"17","author":"Yang","year":"2025","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"83","DOI":"10.32604\/or.2023.028905","article-title":"Progress on Diagnostic and Prognostic Markers of Pancreatic Cancer","volume":"31","author":"Yang","year":"2023","journal-title":"Oncol. Res."},{"key":"ref_56","first-page":"130","article-title":"Catching Pancreatic Cancer Early: Are We There Yet?","volume":"6","author":"Rasheed","year":"2026","journal-title":"J. Natl. Cancer Cent."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"14","DOI":"10.69734\/psc3br75","article-title":"3. SMART Medical Review: CA 19-9 and Pancreatic Ductal Adenocarcinoma (PDAC).: CA 19-9 and Pancreatic Cancer","volume":"1","author":"Whitcomb","year":"2024","journal-title":"SMART-MD J. Precis. Med."},{"key":"ref_58","first-page":"105","article-title":"The Clinical Utility of Serum CA 19-9 in the Diagnosis, Prognosis and Management of Pancreatic Adenocarcinoma: An Evidence Based Appraisal","volume":"3","author":"Ballehaninna","year":"2011","journal-title":"J. Gastrointest. Oncol."},{"key":"ref_59","first-page":"251","article-title":"Carbohydrate Antigen 19-9 (CA 19-9) and Carcinoembryonic Antigen (CEA) in Pancreatic Cancer. Role of Age and Liver Dysfunction","volume":"73","author":"Fabris","year":"1986","journal-title":"Bull. Cancer"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1001\/jamasurg.2026.1810","article-title":"Duke Pancreatic Monoclonal Antigen Type 2 for Monitoring Carbohydrate Antigen 19-9 Nonexpressor Pancreatic Cancer","volume":"161","author":"Omiya","year":"2026","journal-title":"JAMA Surg."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"317","DOI":"10.21037\/hbsn-23-662","article-title":"Prognostic Impact of Tumor Marker Kinetics and Normalization during Neoadjuvant Chemotherapy for Pancreatic Cancer","volume":"13","author":"Hayashi","year":"2024","journal-title":"Hepatobiliary Surg. Nutr."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1245\/s10434-020-09022-3","article-title":"Prognostic Value of the Preoperative Tumor Marker Index in Resected Pancreatic Ductal Adenocarcinoma: A Retrospective Single-Institution Study","volume":"28","author":"Miyata","year":"2021","journal-title":"Ann. Surg. Oncol."},{"key":"ref_63","first-page":"1551","article-title":"Evaluation of Circulating Cell-free DNA as a Molecular Monitoring Tool in Patients with Metastatic Cancer","volume":"19","author":"Hufnagl","year":"2019","journal-title":"Oncol. Lett."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1136\/ijgc-2023-004873","article-title":"Circulating Cell-Free DNA as a Diagnostic and Prognostic Marker for Cervical Cancer","volume":"34","author":"Parida","year":"2024","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Yan, Y., Guo, Q., Wang, F., Adhikari, R., Zhu, Z., Zhang, H., Zhou, W., Yu, H., Li, J., and Zhang, J. (2021). Cell-Free DNA: Hope and Potential Application in Cancer. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.639233"},{"key":"ref_66","first-page":"100259","article-title":"Circulating Cell-Free DNA for Cancer Early Detection","volume":"3","author":"Gao","year":"2022","journal-title":"Innovation"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s13148-019-0728-8","article-title":"Deciphering DNA Methylation Signatures of Pancreatic Cancer and Pancreatitis","volume":"11","author":"Natale","year":"2019","journal-title":"Clin. Epigenet."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2644667","DOI":"10.1080\/15384047.2026.2644667","article-title":"Molecular Mechanisms and Therapeutic Strategies: DNA Methylation in Pancreatic Cancer","volume":"27","author":"Liu","year":"2026","journal-title":"Cancer Biol. Ther."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Saif, M.W., Chang, W.-H., Myers, S., Potts, M., Qazi, S., and Trieu, V. (2025). TGFB2 Expression and Methylation Predict Overall Survival in Pancreatic Ductal Adenocarcinoma Patients. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26136357"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Manne, A., Esnakula, A., Sheel, A., Sara, A., Manne, U., Paluri, R.K., He, K., Yang, W., Sohal, D., and Kasi, A. (2024). Mature MUC5AC Expression in Resected Pancreatic Ductal Adenocarcinoma Predicts Treatment Response and Outcomes. Int. J. Mol. Sci., 25.","DOI":"10.20944\/preprints202407.0605.v1"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Czuczi, T., Mur\u00e1nyi, J., M\u00f3ra, I., Gurbi, B., Varga, A., Papp, D., Schlosser, G., Csala, M., and Cs\u00e1mpai, A. (2024). Development of Novel Imipridones with Alkyne- and Triazole-Linked Warheads on the Tricyclic Skeleton, Showing Superior Ability to Eradicate PANC-1 and Fadu Cells Compared to ONC201. Int. J. Mol. Sci., 25.","DOI":"10.20944\/preprints202410.1974.v1"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"101332","DOI":"10.1016\/j.imu.2023.101332","article-title":"Computer-Aided Drug Design in Anti-Cancer Drug Discovery: What Have We Learnt and What Is the Way Forward?","volume":"41","author":"Iwaloye","year":"2023","journal-title":"Inform. Med. Unlocked"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"26954","DOI":"10.1039\/D4RA03005B","article-title":"Design, Synthesis and Potent Anti-Pancreatic Cancer Activity of New Pyrazole Derivatives Bearing Chalcone, Thiazole and Thiadiazole Moieties: Gene Expression, DNA Fragmentation, Cell Cycle Arrest and SAR","volume":"14","author":"Kamel","year":"2024","journal-title":"RSC Adv."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"109946","DOI":"10.1016\/j.bioorg.2026.109946","article-title":"Design, Synthesis, and Evaluation of Novel Andrographolide Derivatives as Anti-Pancreatic Cancer Therapeutics","volume":"178","author":"Li","year":"2026","journal-title":"Bioorg. Chem."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s40265-025-02252-3","article-title":"Dordaviprone: First Approval","volume":"86","author":"Blair","year":"2026","journal-title":"Drugs"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Del Campo-Pedrosa, R., Mart\u00edn-Carnicero, A., Gonz\u00e1lez-Marcos, A., and Mart\u00ednez, A. (2026). Optimized Chemotherapy Sequence for Metastatic Pancreatic Ductal Adenocarcinoma Patients: FOLFIRINOX Followed by Gemcitabine plus Nab-Paclitaxel. BMC Cancer, 26.","DOI":"10.1186\/s12885-026-16391-7"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Fanijavadi, S., Thomassen, M., and Jensen, L.H. (2025). Targeting Triple NK Cell Suppression Mechanisms: A Comprehensive Review of Biomarkers in Pancreatic Cancer Therapy. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26020515"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Geisler, A., Dieringer, B., Elsner, L., Girod, M., Van Linthout, S., Kurreck, J., and Fechner, H. (2025). Sensitivity of Pancreatic Cancer Cell Lines to Clinically Approved FAK Inhibitors: Enhanced Cytotoxicity Through Combination with Oncolytic Coxsackievirus B3. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26146877"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Ortega, M., Agena, E., Chen, W., Cao, H., Vasudevan, S., Shivapurkar, N., Pierobon, M., and Smith, J.P. (2025). Downregulation of the CCK-B Receptor in Pancreatic Stellate Cells Blocks Molecular Proliferative Pathways and Increases Apoptosis to Decrease Pancreatic Cancer Growth In Vitro. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms262311699"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"e009702","DOI":"10.1136\/jitc-2024-009702","article-title":"Cancer-Associated Fibroblast Targeting Therapies as a Tool to Enhance Responses to Radiotherapy and Immunotherapy","volume":"14","year":"2026","journal-title":"J. Immunother. Cancer"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Fanijavadi, S., and Jensen, L.H. (2025). Dysbiosis\u2013NK Cell Crosstalk in Pancreatic Cancer: Toward a Unified Biomarker Signature for Improved Clinical Outcomes. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26020730"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.trecan.2026.01.011","article-title":"Epigenetic Dysregulation and Microenvironment Remodeling in Pancreatic Cancer","volume":"12","author":"Niu","year":"2026","journal-title":"Trends Cancer"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/s41392-026-02705-5","article-title":"Pancreatic Ductal Adenocarcinoma: Integrating Molecular Insights for Targeted Interventions","volume":"11","author":"Nagaraju","year":"2026","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev-pathmechdis-031621-024600","article-title":"Tumor Microenvironment in Pancreatic Cancer Pathogenesis and Therapeutic Resistance","volume":"18","author":"Sherman","year":"2023","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1158\/0008-5472.CAN-25-1001","article-title":"FNDC4 Drives Metastasis and Immune Evasion in Pancreatic Cancer","volume":"86","author":"Li","year":"2026","journal-title":"Cancer Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s12672-026-05030-z","article-title":"The Mechanisms and Clinical Prospects of Combining Chemotherapy with Immunotherapy for Advanced Pancreatic Cancer","volume":"17","author":"Hua","year":"2026","journal-title":"Discov. Oncol."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Hui, X., Tian, X., Ding, S., Sun, A., Zhao, T., and Wang, H. (2025). Reprogramming the Tumor Microenvironment to Overcome Immunotherapy Resistance in Pancreatic Cancer. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1717062"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s10238-026-02201-8","article-title":"Current Advances in Immunotherapy for KRAS-Mutant Pancreatic Cancer","volume":"26","author":"Li","year":"2026","journal-title":"Clin. Exp. Med."},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Cameron, J.M., Butler, H.J., Palmer, D.S., McHardy, R.G., and Baker, M.J. (2026). Abstract 7616: Early Detection of Pancreatic Cancer with a Multi-Omic Liquid Biopsy. Cancer Res., 86.","DOI":"10.1158\/1538-7445.AM2026-7616"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.semcancer.2024.09.002","article-title":"Unravelling the Complexities of Resistance Mechanism in Pancreatic Cancer: Insights from in Vitro and Ex-Vivo Model Systems","volume":"106\u2013107","author":"Lencioni","year":"2024","journal-title":"Semin. Cancer Biol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/19\/8735\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:15:30Z","timestamp":1790914530000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/19\/8735"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,30]]},"references-count":90,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["ijms27198735"],"URL":"https:\/\/doi.org\/10.3390\/ijms27198735","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,30]]}}}